Want to implement this in your clinic?
Cliniq Flo covers everything in this guide — ABDM, GST billing, OPD management, lab, pharmacy. Book a free 30-minute demo.
Respiratory disease in India carries a unique burden: India has the world's highest COPD mortality, a massive asthma population, and 27% of the global tuberculosis burden. Every clinic doctor in India is, by necessity, a front-line respiratory physician.
Approach to Breathlessness in OPD
Breathlessness is never just "breathlessness" — the differential spans cardiac, respiratory, haematological, and metabolic causes. Structured assessment prevents missing dangerous diagnoses:
- Onset: Acute (minutes) → think PE, pneumothorax, acute LVF, anaphylaxis. Subacute (days) → pneumonia, AECOPD, pleural effusion. Chronic/progressive → COPD, heart failure, ILD, anaemia
- Position: Orthopnoea (worse lying flat) → heart failure. Platypnoea (worse sitting up) → hepatopulmonary syndrome
- Associated symptoms: Wheeze → asthma/COPD. Cough + fever → infection. Chest pain → PE/pneumonia/pneumothorax. Haemoptysis → TB/malignancy/PE
- Examination essentials: SpO₂ (every breathless patient), RR (most neglected vital sign), percussion (dull = effusion/consolidation; hyperresonant = pneumothorax), auscultation
Asthma: Diagnosis and Step-Up Therapy
Diagnosis
Asthma is a clinical diagnosis. Key features: episodic wheeze, breathlessness, chest tightness, cough (especially nocturnal) — variable and reversible. Confirm with spirometry if available: FEV1/FVC <0.7 with ≥12% and 200ml improvement post-bronchodilator.
In Indian children, be aware that GORD, rhinitis, and post-nasal drip are common asthma mimics. Treat comorbidities alongside asthma.
GINA 2024 Step-Up Therapy
COPD: Diagnosis, Staging, and Management
Diagnosis
Suspect COPD in any patient >40 with: chronic productive cough, exertional breathlessness, or history of smoking / biomass fuel exposure (chulha cooking — a major Indian COPD cause, especially in women). Confirm with post-bronchodilator spirometry: FEV1/FVC <0.7.
GOLD Staging and Treatment
| GOLD Stage | FEV1 % Predicted | Initial Treatment |
|---|---|---|
| GOLD 1 (Mild) | ≥80% | SABA PRN + smoking cessation |
| GOLD 2 (Moderate) | 50–79% | LAMA (Tiotropium 18mcg OD) |
| GOLD 3 (Severe) | 30–49% | LAMA + LABA, consider ICS if frequent exacerbations |
| GOLD 4 (Very Severe) | <30% | Triple therapy (ICS+LABA+LAMA) + pulmonology co-management |
All COPD patients regardless of stage: influenza vaccine annually, pneumococcal vaccine (PCV13 + PPSV23), pulmonary rehabilitation referral if available, smoking cessation counselling every visit.
Acute Exacerbation Management in OPD
AECOPD: acute worsening of respiratory symptoms beyond day-to-day variation. Decide: OPD treatment vs hospitalise?
Treat in OPD if all of: SpO₂ ≥92%, able to speak in full sentences, no accessory muscle use, no altered consciousness, good home support
Hospitalise immediately if any of: SpO₂ <90%, RR >30, HR >110, altered consciousness, inability to manage at home, failure to improve with initial treatment
OPD exacerbation protocol:
- Salbutamol 2.5mg nebulisation, repeat at 20 minutes if needed
- Ipratropium 500mcg nebulisation combined with salbutamol
- Prednisolone 40mg OD for 5 days
- Antibiotics if purulent sputum: Amoxicillin-clavulanate 625mg TDS or Doxycycline 100mg BD for 5 days
- Reassess SpO₂ 1 hour after nebulisation before discharge
Inhaler Technique: The Most Overlooked Treatment Failure
Studies show 70–80% of patients use inhalers incorrectly. Before escalating treatment, always assess technique:
pMDI (pressurised metered-dose inhaler) — common errors in India:
- Not shaking before use
- Inhaling too fast (should be slow, over 3–5 seconds)
- Not holding breath for 10 seconds after inhalation
- Firing the inhaler before starting to inhale
A spacer device eliminates most pMDI technique errors and is recommended for all patients, especially children and elderly. A 500ml plastic bottle with a hole cut in the cap works as a spacer in resource-limited settings.
TB Screening in OPD: Every Cough for 2 Weeks
India has 2.8 million new TB cases annually — 27% of the global burden. Every clinic doctor is on the front line of detection.
TB treatment: Do not start treatment without microbiological confirmation if possible. Presumptive TB (CBNAAT negative but strong clinical suspicion): discuss with pulmonologist or DTCO. Nikshay portal: all diagnosed TB patients must be registered. Government provides free ATT (HRZE for 2 months, HR for 4 months) and monthly ₹500 nutritional support (Nikshay Poshan Yojana).
Community-Acquired Pneumonia in OPD
Use the CRB-65 score to decide OPD treatment vs admission:
- Confusion: new onset
- Respiratory rate ≥30/min
- BP <90 systolic or <60 diastolic
- Age ≥65
Score 0: OPD treatment. Score 1–2: Consider admission. Score ≥3: Hospitalise urgently.
OPD CAP treatment: Amoxicillin 500mg–1g TDS for 5 days (first choice). If atypical features (dry cough, bilateral infiltrates, younger patient): add Azithromycin 500mg OD for 3 days. Confirm improvement at 48 hours — failure to improve demands hospitalisation.
Keep respiratory patients on structured follow-up — SpO₂, symptom diary, inhaler reviews. CliniqFlo's appointment system helps schedule 3-month COPD reviews automatically →
Start Using Cliniq Flo in Your Clinic Today
ABDM-ready · GST-compliant · Built for India · Free onboarding · 500+ clinics trust us
Tagged
Explore CliniqFlo
📚Related Articles
COVID-19 in Your OPD: Updated Clinical Guidelines for Indian Clinic Doctors (2026)
A practical guide for Indian clinic doctors on managing COVID-19 patients in 2026 — risk stratificat…
Read →
Clinical InsightsDengue Fever OPD Management: A Complete Guide for Indian Clinic Doctors
Everything Indian clinic doctors need to manage dengue patients effectively — from NS1 testing and w…
Read →
Clinical InsightsMonsoon Season in Your Clinic: Managing Disease Surge and High OPD Volume
Indian clinics see 3–5x OPD surge during monsoon season. This guide covers the top monsoon diseases,…
Read →
